The time has not yet come to remove your chips from the table: Corebridge Financial Inc. (CRBG)

With 1.67 million shares changed hands, the volume of the stock remained lighter than its average volume of 4.0 million shares. During the session, the Asset Management company that operates in wider Financial sector, reached to the highest price of $23.47 whereas the lowest price it dropped to was $23.12. The 52-week range on CRBG shows that it touched its highest point at $25.02 and its lowest point at $12.72 during that stretch. It currently has a 1-year price target of $27.54. With its current market cap of 15.15 billion, CRBG has annualized dividend of $2.69 while the current yield stands at 11.53%. Beta for the stock currently stands at 0.86.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CRBG was down-trending over the past week, with a drop of -0.09%, but this was down by -0.76% over a month. Three-month performance surged to 21.91% while six-month performance rose 34.54%. The stock gained 17.08% in the past year, while it has gained 7.94% so far this year. A look at the trailing 12-month EPS for CRBG yields 2.88 with Next year EPS estimates of 4.92. For the next quarter, that number is 0.97. This implies an EPS growth rate of 40.56% for this year and 21.90% for next year.


Float and Shares Shorts:

At present, 645.00 million CRBG shares are outstanding with a float of 248.12 million shares on hand for trading. On Jan 11, 2024, short shares totaled 5.38 million, which was 0.85% higher than short shares on Dec 14, 2023. In addition to CRBP as the firm’s Corbus Pharmaceuticals Holdings, CRBU serves as its Caribou Biosciences, Inc..

Institutional Ownership:

Through their ownership of 38.16% of CRBG’s outstanding shares, institutional investors have minority control over the company.


Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CRBG since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With CRBG analysts setting a high price target of $33.00 and a low target of $21.00, the average target price over the next 12 months is $27.54. Based on these targets, CRBG could surge 41.15% to reach the target high and fall by -10.18% to reach the target low. Reaching the average price target will result in a growth of 17.79% from current levels.

Summary of Insider Activity:

Insiders traded CRBG stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 19 while that of sell transactions has risen to 19 over the past year. The total number of shares bought during that period was 503,650 while 135,825,230 shares were sold.